July 11, 2023 Comments Off on New patent for Meridian Labs drug DOCETAXEL Posted in: Patent Added Annual Drug Patent Expirations for DOCETAXEL Docetaxel is a drug marketed by Accord Hlthcare, Actavis Llc, Amneal, Apotex Inc, Dfb Oncology Ltd, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Hengrui…
The post New patent for Meridian Labs drug DOCETAXEL ap…
July 11, 2023 Comments Off on New patent for Pharmacyclics Inc drug IMBRUVICA Posted in: Patent Added Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in three NDAs. It is available from one supplier. There are fifty-five patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appe…